AU5996996A - Al/fe-treatment of a protein solution, followed by membrane concentration - Google Patents

Al/fe-treatment of a protein solution, followed by membrane concentration

Info

Publication number
AU5996996A
AU5996996A AU59969/96A AU5996996A AU5996996A AU 5996996 A AU5996996 A AU 5996996A AU 59969/96 A AU59969/96 A AU 59969/96A AU 5996996 A AU5996996 A AU 5996996A AU 5996996 A AU5996996 A AU 5996996A
Authority
AU
Australia
Prior art keywords
protein solution
treatment
followed
membrane concentration
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59969/96A
Other languages
English (en)
Inventor
Mads Aage Laustsen
Niels-Viktor Nielsen
Torben Kjaarsgaard Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU5996996A publication Critical patent/AU5996996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU59969/96A 1995-06-02 1996-05-31 Al/fe-treatment of a protein solution, followed by membrane concentration Abandoned AU5996996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK62695 1995-06-02
DK626/95 1995-06-02
PCT/DK1996/000229 WO1996038469A1 (en) 1995-06-02 1996-05-31 Al/Fe-TREATMENT OF A PROTEIN SOLUTION, FOLLOWED BY MEMBRANE CONCENTRATION

Publications (1)

Publication Number Publication Date
AU5996996A true AU5996996A (en) 1996-12-18

Family

ID=8095720

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59969/96A Abandoned AU5996996A (en) 1995-06-02 1996-05-31 Al/fe-treatment of a protein solution, followed by membrane concentration

Country Status (9)

Country Link
EP (1) EP0828753B1 (enExample)
JP (1) JPH11511118A (enExample)
CN (1) CN1114613C (enExample)
AT (1) ATE235506T1 (enExample)
AU (1) AU5996996A (enExample)
DE (1) DE69626976T2 (enExample)
DK (1) DK0828753T3 (enExample)
IN (1) IN181859B (enExample)
WO (1) WO1996038469A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810667B1 (fr) * 2000-06-23 2004-09-03 Warner Lambert Co Procede d'isolement et de purification d'une proteine, et proteine obtenue
US7659102B2 (en) 2001-02-21 2010-02-09 Verenium Corporation Amylases, nucleic acids encoding them and methods for making and using them
MXPA03007527A (es) 2001-02-21 2004-07-30 Diversa Corp Enzimas que tienen actividad de alfa amilasa y metodos de uso de las mismas.
US20030013172A1 (en) * 2001-05-14 2003-01-16 Joel Gerendash Novel methods of enzyme purification
ES2298378T3 (es) 2001-06-28 2008-05-16 Novo Nordisk A/S Formulacion estable de glp-1 modificado.
US7118891B2 (en) 2001-12-11 2006-10-10 Novozymes A/S Crystal harvest from fermentation broth
ATE547518T1 (de) * 2001-12-11 2012-03-15 Novozymes As Verfahren zur sammlung von kristallinen partikeln aus fermentationsbrühe
CA2515340C (en) 2003-03-06 2016-04-26 Diversa Corporation Amylases, nucleic acids encoding them and methods for making and using them
EP1633391B1 (en) 2003-06-03 2011-10-19 Novo Nordisk A/S Stabilized pharmaceutical peptide compositions
JP4936884B2 (ja) 2003-06-03 2012-05-23 ノボ・ノルデイスク・エー／エス 安定化された薬学的ペプチド組成物
KR101243648B1 (ko) 2003-11-20 2013-03-14 노보 노르디스크 에이/에스 제조 및 주사 장치용에 최적인 프로필렌 글리콜 함유펩티드 제제
JP4965446B2 (ja) 2004-08-31 2012-07-04 ノヴォ ノルディスク アー／エス ペプチド、ポリペプチド及びタンパク質の安定化のためのトリス（ヒドロキシメチル）アミノメタンの使用
MX2007005521A (es) 2004-11-12 2007-05-18 Novo Nordisk As Formulaciones estables de peptidos insulinotropicos.
US7855280B2 (en) 2005-09-15 2010-12-21 Wyeth Llc Separation methods
ES2531167T5 (es) 2006-12-21 2018-05-21 Basf Enzymes Llc Amilasas y glucoamilasas, ácidos nucleicos que las codifican y métodos para formarlas y utilizarlas
US20120252066A1 (en) * 2011-03-29 2012-10-04 Heng Meng H Methods of foam control
WO2014068083A1 (en) 2012-11-01 2014-05-08 Novozymes A/S Method for removal of dna
DK3071589T3 (en) 2013-11-19 2018-06-14 Kemira Oyj METHOD OF REDUCING THE COLOR OF A BIOTECHNOLOGICAL LIQUID
CN118903385A (zh) 2017-08-24 2024-11-08 诺和诺德股份有限公司 Glp-1组合物及其用途
CN108949703A (zh) * 2018-06-28 2018-12-07 大连理工大学 一种半纤维小体类似物粗提纯方法
FI3983425T3 (fi) 2019-06-13 2025-11-19 Basf Se Menetelmä proteiinin talteen ottamiseksi käymisliemestä käyttämällä divalenttista kationia
EP4537848A3 (en) 2020-02-18 2025-06-25 Novo Nordisk A/S Glp-1 compositions and uses thereof
EP4217366A1 (en) 2020-09-22 2023-08-02 Basf Se Method for recovering a protein from a fermentation broth comprising a high degree of lysed cells
CN112500471B (zh) * 2020-12-22 2022-09-27 中美华世通生物医药科技(武汉)股份有限公司 一种制备高澄清度蛋白琥珀酸铁的方法
EP4565711A1 (en) 2022-08-02 2025-06-11 Basf Se Stabilized protein production process using bacillus host cells with salt feed

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3795586A (en) * 1969-08-11 1974-03-05 Pabst Brewing Co Recovery of enzymes
EP0277043A3 (en) * 1987-01-30 1989-08-23 IMCERA Group Inc. Method for recovering somatotropins from dilute aqueous solution
US4894444A (en) * 1987-07-16 1990-01-16 Merck & Co., Inc. Recovery and purification of immunogens from immunogen-alum complexes
DE3915277A1 (de) * 1989-05-10 1990-11-15 Henkel Kgaa Verfahren zur reinigung von enzymfluessigkonzentraten
DE4037530A1 (de) * 1990-11-26 1992-05-27 Henkel Kgaa Faellungsverfahren fuer exocellulaere proteine
DK91092D0 (enExample) * 1992-07-10 1992-07-10 Novo Nordisk As

Also Published As

Publication number Publication date
ATE235506T1 (de) 2003-04-15
DK0828753T3 (da) 2003-06-30
JPH11511118A (ja) 1999-09-28
DE69626976D1 (de) 2003-04-30
CN1186498A (zh) 1998-07-01
EP0828753B1 (en) 2003-03-26
WO1996038469A1 (en) 1996-12-05
EP0828753A1 (en) 1998-03-18
DE69626976T2 (de) 2004-03-04
IN181859B (enExample) 1998-10-03
CN1114613C (zh) 2003-07-16

Similar Documents

Publication Publication Date Title
AU5996996A (en) Al/fe-treatment of a protein solution, followed by membrane concentration
CA2287267A1 (en) Improved methods for processing activated protein c
BR9608729A (pt) Preparação de um pó de proteína acilada
CA2217669A1 (en) Process for isolating a protein composition from a muscle source and protein composition
MY127603A (en) Method to remove citrate and aluminum from proteins
CA2224896A1 (en) Purified heat-coagulated potato protein for use in animal feed
DK0840792T3 (da) (S)-hydroxynitrillyase fra Hevea brasiliensis
AU4876196A (en) A process for the preparation of factor ix from biological sources
FI950094A0 (fi) Menetelmä vesipohjaisen entsyymiliuoksen puhdistamiseksi
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
UA39178C2 (uk) Спосіб мінімізації деградації активованого протеїну с (варіанти), фармацевтична композиція та водний розчин активованого протеїну с
DE69613685D1 (de) D-aminosäure-oxidase kodierendes dns-fragment
AU7126996A (en) Aqueous solutions of formic acid, propionic acid and ammonia and the use thereof
AU4654097A (en) Rdgb-proteins
AU5417696A (en) Substituted tetronic acids useful for treating hiv and other retroviruses
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
AU8941091A (en) Method for purifying concentrated, aqueous and used solutions of chromic acid, and solutions thereby purified
DE3270177D1 (en) Process for purifying elastase
SE9702993D0 (sv) Anti-mikrobial komposition
AU6661394A (en) Purification of fluoronucleosides
AU6695896A (en) Process for regeneration of an aqueous process liquid of the amine-oxide process
UA8125A1 (uk) Спосіб підготовки води